Watch Ticker

Quoin Pharmaceuticals, Ltd. American Depositary Shares

Go to Quoin Pharmaceuticals, Ltd. American Depositary Shares Website

$6.87

0.18 (2.62%)

Live

Previous Close

$6.695

Day Range

$6.8702 - $7.3221

Previous Day Range

$6.625 - $6.8

Market Cap

$4.0 million USD

Day Vol.

2786

Previous Day Vol.

2420

Currency

USD

Primary Exchange

Nasdaq

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potent...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Prism Marketview - PRISM MarketView Spotlights Quoin Pharmaceuticals CEO Dr. Michael Myers as Specialty Pharma Shares News of Highly Positive Interim Data in Most Advanced, Comprehensive Netherton Syndrome Trials

Quoin Pharmaceuticals announced highly positive interim data from its ongoing Netherton Syndrome clinical trials, with the first subject demonstrating marked improvements across all measured endpoints after 12 weeks of treatment with the company's QRX003 topical lotion. The company is optimistic about the therapy's potential to effectively treat this rare and debilitating skin disease.

Related tickers: QNRX.

Read Full Article

Quoin Pharmaceuticals, Inc. - Quoin Pharmaceuticals to Sponsor the Foundation for Ichthyosis & Related Skin Types (FIRST) 2024 National Conference

ASHBURN, Va., June 25, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage specialty pharmaceutical company focused on rare and orphan diseases, today announces that it will be a Bronze Sponsor for the Foundation for Ichthyosis & Related Skin Types (FIRST) 2024 national conference in Albuquerque, New Mexico from June 28-30, 2024.

Related tickers: QNRX.

Read Full Article

Trending Tickers

Please sign in to view